Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Rankning i aktier #32327
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Aktiekurs
$0.88
Senast synkroniserad: 2026-08-17
Marknadsvärde
$10.41M
Förändring (1 dag)
-7.26%
Förändring (1 år)
-50.56%
Land
SG
Handel CytoMed Therapeutics Limited (GDTC)

Kategori

Aktiekurshistorik för CytoMed Therapeutics Limited (GDTC)
Högsta slutkurs: $0.84 den 2026-08-01

Lägsta slutkurs: $3.48 den 2023-04-01
Aktiekurshistorik för CytoMed Therapeutics Limited från 2023 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -14.06%
2025 -41.13%
2024 -30.38%
2023 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$736.64 6.99%
CH
$1.07K -6.01%
KR
$255.50 12.02%
BE